Anxiety conditioned to nicotine in the elevated plus-maze is time dependent

Behavioural Pharmacology

Volumn 13, Issue 8, 2002, Pages 615-620

  Tucci, Sonia ^a   Cheeta, S ^a   Genn, R F ^a   Seth, P ^a   File, S E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Anxiety; Classical conditioning; Elevated plus maze; Nicotine; Rat

Indexed keywords

NICOTINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; ASSOCIATION; CONDITIONING; CONTROLLED STUDY; MALE; NONHUMAN; PSYCHOLOGIC TEST; RAT; TASK PERFORMANCE; TIME;

EID: 0036968289     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200212000-00002     Document Type: Article

References (43)

1. Berger SP, Hall S, Mickalian JD, Reid MS, Crawford CA, Delucchi K, et al. (1996). Haloperidol antagonism of cue-elicited cocaine craving. Lancet 347:504-508.
2. Bevins RA, Besheer J, Pickett KS (2001). Nicotine-conditioned locomotor activity in rats: dopaminergic and GABAergic influences on conditioned expression. Pharmacol Biochem Behav 68:135-145.
3. Brioni JD, O'Neill AB, Kim DJ, Decker MW (1993). Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. Eur J Pharmacol 238:1-8.
4. Caggiula AR, Donny E, White A, Chaudhri N, Booth S, Gharib M, et al. (2001). Cue dependency of nicotine self-administration and smoking. Pharmacol Biochem Behav 70:515-530.
5. Cao W, Burkholder T, Wilkins L, Collins AC (1993). A genetic comparison of behavioral actions of ethanol and nicotine in the mirrored chamber. Pharmacol Biochem Behav 45:803-809.
6. Cheeta S, Irvine E, File SE (2001). Social isolation modifies nicotine's effects in animal tests of anxiety. Br. J. Pharmacol 132:1389-1395.
7. Cheeta S, Kenny PJ, File SE (2000a). Hippocampal and septal injections of nicotine and 8-OH-DPAT distinguish among different animal tests of anxiety. Prog Neuropsychopharmacol Biol Psychiatry 24:1053-1067.
8. Cheeta S, Kenny PJ, File SE (2000b). The role of 5-HT1A receptors in mediating the anxiogenic effects of nicotine following lateral septal administration. Eur J Neurosci 12:3797-3802.
9. Corrigal WA (1999). Nicotine self administration in animals as a dependence model. Nicotine Tobacco Res 1:11-20.
10. Costall B, Kelly ME, Naylor RJ, Onaivi ES (1989). The actions of nicotine and cocaine in a mouse model of anxiety. Pharmacol Biochem Behav 33:197-203.
11. DeVries AC, Pert A (1998). Conditioned increases in anxiogenic-like behavior following exposure to contextual stimuli associated with cocaine are mediated by corticotropin-releasing factor. Psychopharmacology 137:333-340.
12. Fernandes C, File SE (1996). The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol Biochem Behav 54:31-40.
13. File SE (1990). One trial tolerance to anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology 100:281-282.
14. File SE (1992). Behavioural detection of anxiolytic action. In: Experimental Approaches to Anxiety and Depression. Elliott JM, Heal DJ, Marsden CA (editors). London: John Wiley, pp. 495-499.
15. File SE (1993). The interplay of learning and anxiety in the elevated plus-maze. Behav Brain Res 58:199-202.
16. File SE, Zangrossi H (1993). One-trial tolerance to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state? Psychopharmacology 110:240-244.
17. File SE, Mabbutt PS, Hitchcott PK (1990). Characterisation of the phenomenon of 'one-trial tolerance' to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology 102:98-101.
18. File SE, Kenny PJ, Ouagazzal A-M (1998). Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus. Behav Neurosci 112:1423-1429.
19. File SE, Fluck E, Leahy A (2001a). Nicotine has calming effects on stress-induced mood changes in females, but enhances aggressive mood in males. Int J Neuropsychopharmacol 4:371-376.
20. File SE, Irvine E, Cheeta S, Akhtar M, Tucci S, Seth P (2001b). Nicotine and conditioned anxiety. Soc Neurosci Abstr 27:222011.
21. File SE, Cheeta S, Irvine E, Tucci S, Akhtar M (2002). Conditioned anxiety to nicotine. Psychopharmacology 164:309-317.
22. 14C]nicotine. Drug Metab Dispos 27:1448-1455.
23. Gonzalez LE, File SE (1997). A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus. J Neurosci 17:1505-1511.
24. 1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Brain Res 732:145-153.
25. Gonzalez LE, Ouagazzal AM, File SE (1998). Stimulation of benzodiazepine receptors in the dorsal hippocampus and median raphe reveals differential GABAergic control in two animal tests of anxiety. Eur J Neurosci 10:3673-3680.
26. Irvine EE, Cheeta S, File SE (1999). Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine. Behav Pharmacol 10:691-697.
27. Irvine E, Cheeta S, File S (2001). Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal. Pharmacol Biochem Behav 68:319-325.
28. Lister RG (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180-185.
29. Netter P, Hennig J, Huwe S, Olbrich R (1998). Personality related effects of nicotine, mode of application, and expectancies on performance, emotional states, and desire for smoking. Psychopharmacology 135:52-62.
30. Newhouse PA, Sunderland T, Narang PK. Mellow AM, Fertig JB, Lawlor BA, Murphy DL (1990). Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with Alzheimer's disease. Psychoneuroendocrinology 15:471-484.
31. Ouagazzal A-M, Kenny P, File SE (1999a). Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety. Eur J Neurosci 11:3957-3962.
32. Ouagazzal A-M, Kenny P, File SE (1999b). Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine. Psychopharmacology 144:54-60.
33. Pellow S, File SE (1986). Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24:525-529.
34. Pellow S, Chopin PH, File S.E, Briley M (1985). Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth 14:149-167.
35. Reid MS, Ho LB, Berger SP (1996). Effects of environmental conditioning on the development of nicotine sensitization: behavioral and neurochemical analysis. Psychopharmacology 126:301-310.
36. Reid MS, Mickalian JD, Delucchi KL, Hall SM, Berger SP (1998). An acute dose of nicotine enhances cue-induced cocaine craving. Drug Alcohol Depend 49:95-104.
37. Rodgers RJ, Johnson NJ, Cole JC, Dewar CV, Kidd GR, Kimpson PH (1996). Plus-maze retest profile in mice: importance of initial stages of trial 1 and response to post-trial cholinergic receptor blockade. Pharmacol Biochem Behav 54:41-50.
38. Rose JE, Corrigal WA (1997). Nicotine self-administration in animals and humans: similarities and differences. Psychopharmacology 130:28-40.
39. Sastry BV, Chance MB, Singh G, Horn JL, Janson VE (1995). Distribution and retention of nicotine and its metabolite, cotinine, in the rat as a function of time. Pharmacology 50:128-136.
40. Treit D, Menard J, Royan C (1993). Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44:463-469.
41. Tucci S, Cheeta S, Seth P, File SE (2002). CRF mediates conditioned anxiety to nicotine. Eur Neuropsychopharmacol 12(Suppl. 3):Abstract P.3.007.
42. Vale AL, Green S (1986). Effects of chlordiazepoxide, nicotine and D-amphetamine in the rat potentiated startle model of anxiety. Behav Pharmacol 7:138-143.
43. Walter S, Kuschinsky K (1989). Conditioning of nicotine effects on motility and behaviour in rats. Naunyn Schmiedeberg's Arch Pharmacol 339:208-213.